Atlas

FDA-Inspected Site

Kabco Pharmaceuticals, Inc.

11 FDA inspections are on record for Kabco Pharmaceuticals, Inc. in Amityville, United States.

483· Form 483 issued

Amityville, United States · Last updated July 10, 2026

Overview

  • 11 FDA inspections are on record.
  • 9 inspections produced a Form 483.
  • The most recent recorded inspection date is 2019-10-04.

At a glance

Inspections

11

Form 483s

9

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
26 Sep 2019 – 4 Oct 2019Foods & Cosmetics483View 483 →
25 Sep 2018 – 2 Oct 2018Foods & Cosmetics483View 483 →
30 Nov 2016 – 9 Dec 2016Foods & Cosmetics483On file
15 Jun 2015 – 30 Jun 2015Foods & Cosmetics483On file
9 Jan 2014 – 10 Jan 2014Foods & CosmeticsClean
15 Nov 2013 – 26 Nov 2013Foods & Cosmetics483View 483 →
2 Apr 2013 – 12 Apr 2013Foods & Cosmetics483View 483 →
21 Oct 2011Not recorded483View 483 →
18 May 2011Not recorded483On file
7 Jul 2010Not recordedWLView 483 →
10 Mar 2008Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

4 Oct 2019
21 CFR 111.15(b)(2)

Physical plant - repair

Cited by Meredith P Soehl

4 Oct 2019
21 CFR 111.16

Written procedures - cleaning

Cited by Meredith P Soehl

4 Oct 2019
21 CFR 111.255(b)

Batch record - complete

Cited by Meredith P Soehl

4 Oct 2019
21 CFR 111.260(m)

Batch record - performance

Cited by Meredith P Soehl

2 Oct 2018
n/a

Procedural requirements

Cited by Meredith P Soehl

Investigators

FDA investigators tied to this site in the record.

Meredith P Soehl8 insp.
Jose O Hernandez1 insp.
Edouard Viard1 insp.
Sarah A Meehan1 insp.
Ann M Stewart1 insp.
Frank Verni1 insp.
Iram R Hassan1 insp.
Stephanie Durso1 insp.
Thomas J Mooney1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations3x
21 CFR 111.205(a)Cited across public-safe Form 483 observations2x
21 CFR 111.210(g)Cited across public-safe Form 483 observations2x
21 CFR 111.365(i)Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations2x
21 CFR 111.110(c)Cited across public-safe Form 483 observations1x
21 CFR 111.123Cited across public-safe Form 483 observations1x
21 CFR 111.123(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.15(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.15(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.153Cited across public-safe Form 483 observations1x
21 CFR 111.16Cited across public-safe Form 483 observations1x
21 CFR 111.210(a)Cited across public-safe Form 483 observations1x
21 CFR 111.210(h)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.25(c)Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.260(l)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.260(m)Cited across public-safe Form 483 observations1x
21 CFR 111.27(a)(5)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.27(b)Cited across public-safe Form 483 observations1x
21 CFR 111.303Cited across public-safe Form 483 observations1x
21 CFR 111.320(b)Cited across public-safe Form 483 observations1x
21 CFR 111.365(a)Cited across public-safe Form 483 observations1x
21 CFR 111.453Cited across public-safe Form 483 observations1x
21 CFR 111.455(c)Cited across public-safe Form 483 observations1x
21 CFR 111.553Cited across public-safe Form 483 observations1x
21 CFR 111.560(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x
21 CFR 111.75(h)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.77(b)Cited across public-safe Form 483 observations1x
21 CFR 111.83(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.90(b)(1)Cited across public-safe Form 483 observations1x
n/aCited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Kabco Pharmaceuticals, Inc.'s 9 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat